Shares of Adaptive Biotechnologies double in hot IPO
Adaptive Biotechnologies' first day as a public company is one for the record books. Shares in the Seattle-based biotech, which specializes in genetically targeted medicine, closed…
Adaptive Biotechnologies' first day as a public company is one for the record books. Shares in the Seattle-based biotech, which specializes in genetically targeted medicine, closed…